Vote and conclusions

Date 01 October 2012
Event ESMO Congress 2012
Session Can neo-adjuvant breast cancer data be used to accelerate drug approval?
Topics Anticancer agents
Breast Cancer
Therapy
Biological therapy
Presenter Hans-Joerg Senn
Authors H. Senn
  • Tumor-und Brustzentrum ZeTuP AG, CH-9006 - St. Gallen/CH